Abstract

Objective: To study the influence of a- and β-adrenoceptor stimulation in vivo on fibrinolysis in healthy male volunteers. Design: Infusions were given in a single blind fashion and in a randomized order if placebo infusions were included. Setting: University Department (Karolinska Hospital). Subjects: Thirty-four healthy, non-smoking male volunteers aged 21–38 years. Interventions: Study 1 - The volunteers participated in two or three separate experiments; 30 min infusions of saline placebo, phentolamine (500 μg/min) or propranolol (bolus dose of 140 μg/kg + 0.5 μg/kg/min) followed by the addition of a 30 min adrenaline infusion (0.4 nmol/kg/min), n=10 in each group. Study 2 - Infusion of a low and an intermediate-high dose of noradrenaline (0.15 and 0.75 nmol/kg/min; 20 min at each dose level), n=11. Study 3— Infusion of a low and high dose of isoprenaline (5 and 20 ng/kg/min), each during 20 min, n=10. Main outcome measures: Venous plasma tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) antigen and activity levels, and plasma levels of urokinase (u-PA) antigen. Results: t-PA activity and antigen levels were markedly increased during adrenaline infusion (by 309±35 and 81±16% respectively, both P<0.01) with a concomitant decrease in PAI-1 activity. U-PA antigen levels increased to a lesser extent. Propranolol, but not phentolamine, attenuated or blunted the effects of adrenaline. Non-selective β-adrenoceptor stimulation by isoprenaline caused smaller, but similar and dose-dependent alterations in fibrinolytic parameters as observed during adrenaline infusions, except for u-PA antigen levels that remained unaltered. A small increase in t-PA activity (by 55±13%, P<0.001) was observed during noradrenaline infusion, whereas t-PA antigen levels only tended to increase, PAI-1 activity decreased and u-PA antigen levels were not affected. Conclusion: Catecholamine-induced increases in plasma levels of t-PA, and to some extent u-PA, are mainly β-adrenoceptor mediated, whereas α-adrenoceptors are of minor importance.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.